Molecular Partners AG (MOLN) Balance Sheet

NASDAQ: MOLNAssets, liabilities, debt and equity over 10 years.

MOLN balance sheet, 2025

December 31, 2025 · Swiss francs

CHF 102.1M assets = CHF 21.8M liabilities + CHF 80.3M equity

What it ownsCHF 102.1MCash & ST investments: CHF 93.1M (91.1%)Cash & ST investmentsCHF 93.1M · 91%Receivables: CHF 1.9M (1.9%)Other current: CHF 1.9M (1.9%)PP&E: CHF 5.2M (5.1%)Goodwill & intangibles: CHF 2,000 (0.0%)=How it is financedCHF 102.1MCurrent liabilities: CHF 11.0M (10.8%)CHF 11.0MOther LT liabilities: CHF 10.7M (10.5%)CHF 10.7MShareholders’ equity: CHF 80.3M (78.7%)Shareholders’ equityCHF 80.3M · 79%

Both columns are drawn to the same scale: what MOLN owns equals what it owes plus shareholders’ equity. Hover a block for its value.

MOLN financial health

Current ratio8.79
Comfortable · current assets cover current liabilities 8.79×
Debt / equity0.05
Low leverage · CHF 0.05 of debt for each $1 of equity
Equity / assets78.7%
Equity-funded · of assets funded by shareholders
Cash / debt2,553.7%
Cash covers debt · cash & short-term investments vs total debt
Goodwill & intangibles0.0%
Mostly tangible · of total assets

Descriptive bands, not a rating. Fiscal 2025.

MOLN balance sheet trends, 2016–2025

Molecular Partners AG balance sheet trends
MetricTrendThenLatestChange
Total assetsCHF 184.1M2016CHF 102.1M2025−6.3%/yr
Total liabilitiesCHF 48.3M2016CHF 21.8M2025−8.5%/yr
Shareholders’ equityCHF 135.8M2016CHF 80.3M2025−5.7%/yr
Cash & short-term investmentsCHF 180.2M2016CHF 93.1M2025−7.1%/yr
Total debtCHF 2.5M2019CHF 3.6M2025+6.2%/yr
Net cash (debt)CHF 92.5M2019CHF 89.4M2025CHF 3.1M
Working capitalCHF 165.8M2016CHF 85.8M2025CHF 79.9M
Current ratio11.5220168.792025−2.73
Debt / equity0.0520190.0520250.00
Shares outstanding20.4M201637.3M2025+6.9%/yr

Change is the average annual growth (CAGR) or the difference between the first and latest year.

MOLN assets

Cash & ST investmentsReceivablesInventoryOther currentPP&EGoodwill & intangiblesLT investmentsOther non-current

MOLN liabilities and equity

Current liabilitiesLong-term debtOther long-term liabilitiesEquity

MOLN debt vs cash

Total debtCash & ST investmentsNet cash (debt)

Debt includes short- and long-term borrowings and, where reported, lease obligations.

MOLN balance sheet in Swiss francs

Molecular Partners AG annual balance sheet
2025202420232022202120202019201820172016
Assets
Cash & short-term investmentsCHF 93.1MCHF 149.4MCHF 186.9MCHF 249.1MCHF 132.8MCHF 173.7MCHF 95.1MCHF 99.0MCHF 141.1MCHF 180.2M
Cash & equivalentsCHF 82.7MCHF 63.9MCHF 67.3MCHF 87.9MCHF 71.8MCHF 133.7MCHF 75.7MCHF 99.0MCHF 131.3MCHF 149.7M
Short-term investmentsCHF 10.4MCHF 85.6MCHF 119.6MCHF 161.2MCHF 61.0MCHF 40.0MCHF 19.4MCHF 0CHF 9.7MCHF 30.5M
ReceivablesCHF 1.9MCHF 286,000CHF 3.1MCHF 1.7MCHF 25.7MCHF 2.8MCHF 2.5MCHF 51.6MCHF 1.2MCHF 844,000
InventoryCHF 0CHF 0CHF 0CHF 0CHF 2−CHF 199,000−CHF 486,000−CHF 2.3M−CHF 9.4M−CHF 844,000
Other current assetsCHF 1.9MCHF 4.6MCHF 2.5MCHF 3.9MCHF 5.7MCHF 1.5MCHF 2.8MCHF 5.0MCHF 9.7MCHF 1.3M
Total current assetsCHF 96.9MCHF 154.3MCHF 192.5MCHF 254.8MCHF 164.2MCHF 177.8MCHF 99.9MCHF 153.3MCHF 142.5MCHF 181.6M
Property, plant & equipment (net)CHF 5.2MCHF 4.2MCHF 5.7MCHF 7.2MCHF 8.1MCHF 9.4MCHF 4.2MCHF 1.5MCHF 1.9MCHF 2.5M
Goodwill & intangible assetsCHF 2,000CHF 49,000CHF 212,000CHF 271,000CHF 330,000CHF 347,000CHF 772,000CHF 382,000CHF 27,000CHF 47,000
Long-term investmentsCHF 0CHF 0CHF 0CHF 0CHF 0CHF 0CHF 0CHF 0CHF 0CHF 0
Other non-current assetsCHF 0CHF 0CHF 0CHF 0CHF 1,000CHF 0CHF 0CHF 0CHF 0CHF 0
Total assetsCHF 102.1MCHF 158.5MCHF 198.4MCHF 262.3MCHF 172.7MCHF 187.5MCHF 104.9MCHF 155.2MCHF 144.4MCHF 184.1M
Liabilities
Accounts payableCHF 937,000CHF 679,000CHF 410,000CHF 997,000CHF 4.9MCHF 2.8MCHF 2.0MCHF 2.1MCHF 716,000CHF 1.0M
Short-term debtCHF 1.2MCHF 1.2MCHF 1.2MCHF 1.2MCHF 1.2MCHF 1.2MCHF 1.3M———
Deferred revenue——CHF 4.3MCHF 6.4MCHF 28.3MCHF 42.9MCHF 18.3MCHF 27.8MCHF 8.9MCHF 10.5M
Total current liabilitiesCHF 11.0MCHF 10.8MCHF 14.4MCHF 17.3MCHF 46.9MCHF 57.7MCHF 28.6MCHF 36.9MCHF 14.1MCHF 15.8M
Long-term debtCHF 0CHF 0CHF 0CHF 0CHF 0CHF 0CHF 0CHF 0CHF 0CHF 0
Lease obligationsCHF 3.6MCHF 2.4MCHF 3.7MCHF 4.8MCHF 6.0MCHF 7.2MCHF 2.5M———
Other long-term liabilitiesCHF 10.7MCHF 6.1MCHF 7.5MCHF 9.8MCHF 18.5MCHF 22.7MCHF 22.2MCHF 26.6MCHF 13.6MCHF 32.5M
Total liabilitiesCHF 21.8MCHF 16.9MCHF 21.9MCHF 27.1MCHF 65.4MCHF 80.3MCHF 50.8MCHF 63.5MCHF 27.7MCHF 48.3M
Shareholders' equity
Common stock & paid-in capitalCHF 4.0MCHF 4.0MCHF 3.6MCHF 3.6MCHF 3.2MCHF 2.9MCHF 2.2MCHF 2.1MCHF 2.1MCHF 2.1M
Retained earnings (deficit)−CHF 311.8M−CHF 246.3M−CHF 191.8M−CHF 127.8M−CHF 250.9M−CHF 195.2M−CHF 130.9M−CHF 89.9M−CHF 60.7M−CHF 37.3M
Accumulated other comprehensive income——CHF 0−CHF 981,000—CHF 0−CHF 8.9M−CHF 6.9M−CHF 6.1M−CHF 5.1M
Total shareholders' equityCHF 80.3MCHF 141.6MCHF 176.4MCHF 235.2MCHF 107.3MCHF 107.2MCHF 54.1MCHF 91.7MCHF 116.7MCHF 135.8M
Key figures
Total debtCHF 3.6MCHF 2.4MCHF 3.7MCHF 4.8MCHF 6.0MCHF 7.2MCHF 2.5M———
Net cash (debt)CHF 89.4MCHF 147.0MCHF 183.2MCHF 244.3MCHF 126.8MCHF 166.5MCHF 92.5M———
Working capitalCHF 85.8MCHF 143.5MCHF 178.0MCHF 237.5MCHF 117.3MCHF 120.1MCHF 71.3MCHF 116.5MCHF 128.4MCHF 165.8M
Tangible book valueCHF 80.3MCHF 141.6MCHF 176.2MCHF 234.9MCHF 107.0MCHF 106.9MCHF 53.4MCHF 91.3MCHF 116.7MCHF 135.7M
Shares outstanding37.3M34.0M32.8M33.3M31.0M25.0M21.4M21.2M20.9M20.4M
Current ratio8.7914.3113.3514.773.503.083.494.1610.0811.52
Quick ratio8.6113.8813.1814.543.383.063.414.0810.0611.49
Debt / equity0.050.020.020.020.060.070.05———
Equity / assets78.7%89.3%88.9%89.7%62.1%57.2%51.6%59.1%80.8%73.8%

Quarterly columns are labeled by the month the quarter ended. Figures in Swiss francs as reported (latest annual report filed March 12, 2026); data from EODHD.

MOLN financial position

At the end of fiscal 2025 (December 31, 2025), Molecular Partners had total assets of CHF 102.1 million (down 35.6% from a year earlier), total liabilities of CHF 21.8 million and shareholders' equity of CHF 80.3 million. It held CHF 93.1 million in cash and short-term investments against CHF 3.6 million of debt, a net cash position of CHF 89.4 million. Its current ratio was 8.79. In the latest quarter (ended June 30, 2026) total assets were CHF 75.4 million and equity CHF 58.3 million.

Related: MOLN income statement, MOLN cash flow statement, MOLN key metrics. See the MOLN stock overview for the latest quote and news.

MOLN balance sheet FAQ

What are Molecular Partners's total assets?

Molecular Partners reported total assets of CHF 102.1 million at the end of fiscal 2025 (December 31, 2025), compared with CHF 158.5 million a year earlier.

How much debt does Molecular Partners have?

Molecular Partners had CHF 3.6 million of total debt at the end of fiscal 2025, including short-term borrowings and lease obligations. Its debt-to-equity ratio was 0.05.

How much cash does Molecular Partners have?

Molecular Partners held CHF 93.1 million in cash and short-term investments at the end of fiscal 2025; with CHF 3.6 million of debt that is net cash of CHF 89.4 million.

What is Molecular Partners's book value?

Molecular Partners's shareholders' equity (book value) was CHF 80.3 million at the end of fiscal 2025.

What is Molecular Partners's current ratio?

Molecular Partners had current assets of CHF 96.9 million and current liabilities of CHF 11.0 million, a current ratio of 8.79 (it can cover its short-term obligations).

How much goodwill does Molecular Partners have?

Molecular Partners carried CHF 0.0 million of goodwill and intangible assets, 0.0% of total assets, at the end of fiscal 2025.

Biotechnology: balance sheet